01/19/2022 Watchlist Chart
January 19, 2022 News Watchlist
$IMMX – Announced positive interim clinical trial safety data demonstrating 100% completion of IMX-110 planned treatment cycles in its ongoing Phase 1b/2a clinical trial.
$SBEV – Announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph’s Grocery stores. Ralph’s Grocery, a division of The Kroger Company.
$YNDX – Citi analyst Catherine O’Neill lowered the firm’s price target on Yandex to $75 from $90 and keeps a Buy rating on the shares.
$ASML – beats by $€0.63, misses on revs; guides FY22 revs above consensus.
$SOFI – SoFi Technologies shares surged in premarket trading Wednesday after the financial-technology company received regulatory clearance to become a bank holding company. bank approval should be positive catalyst, says Citi – Citi analyst Ashwin Shirvaikar keeps a Buy rating on SoFi Technologies with a $20 price target after the Office of the Comptroller of the Currency conditionally approved the company’s bank charter application.
$TSLA – gapping up with markets.
$NVDA – gapping up with markets.
$UL – S&P Places UL ‘A+’ ratings on Credit Watch Negative on potential acquisition of GSK Consumer HealthCare.
$ABBV – JP Morgan raises target price to $165 from $140 Earnings in a few weeks and another big price increase from a good firm.